- English
- Français

Our Company
For Patients
Investors & Media
- Investor Overview
- News

Lysosomal Storage Disorders at 16th Annual WORLDSymposium™ 2020

February 13, 2020

This event has passed.

Poster presentation

+ Google Calendar + iCal Export

Details

Date:: February 13, 2020

Search

Recent Posts

Lysogene secures a €4.3 million non-dilutive financing from Bpifrance to support its development
Lysogene Announces a Presentation of its LYS-GM101 Program at the ESGCT 2021
Lysogene Reports its Cash Position as of 30 September 2021
LYSOGENE Reports First Half 2021 Financial Results and Provides Operational Update
Lysogene Announces First Patient in the United States Dosed with LYS-GM101 Investigational Gene Therapy for the Treatment of GM1 Gangliosidosis

Lysogene COVID-19 update

Lysogene is developing therapies for children with CNS diseases.

Delivering Gene Therapy’s Promise

About Us
Our Science
Meet the Team
Diseases
Resources

Contact Us
Careers
Transparency
Compassionate Use Policy

©2020 Lysogene. All rights reserved.

Get In Touch

Don’t hesitate to contact us if you need more help.

I agree that any personal data collected by Lysogene will be processed in accordance with Lysogene’s data privacy policy.

Close Menu

Our Company
For Patients
Investors & Media
- Investor Overview
- News

Our Company
For Patients
Investors & Media
- Investor Overview
- News

Start Typing

English
Français

We use cookies to ensure that we give you the best experience on our website. By accepting, you are agreeing to our use of cookies per our privacy policy.Accept Decline Privacy policy